Johnson & Johnson (JNJ)

JNJ (NYSE:Drugs) EQUITY
$90.95
neg -1.70
-1.80%
Today's Range: 90.92 - 91.87 | JNJ Avg Daily Volume: 8,162,900
Last Update: 09/04/15 - 12:33 PM EDT
Volume: 4,183,271
YTD Performance: -11.41%
Open: $91.58
Previous Close: $92.64
52 Week Range: $81.79 - $109.49
Oustanding Shares: 2,769,106,237
Market Cap: 258,496,067,224
6-Month Chart
TheStreet Ratings Grade for JNJ
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 6 6
Moderate Buy 2 2 2 2
Hold 7 7 7 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.07 2.07 2.07 2.07
Latest Dividend: 0.75
Latest Dividend Yield: 3.21%
Dividend Ex-Date: 08/21/15
Price Earnings Ratio: 16.43
Price Earnings Comparisons:
JNJ Sector Avg. S&P 500
16.43 16.40 24.50
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-7.44% -10.72% 37.39%
GROWTH 12 Mo 3 Yr CAGR
Revenue 4.20 0.14 0.05
Net Income 18.00 0.69 0.19
EPS 18.60 0.64 0.18
Earnings for JNJ:
EBITDA 24.85B
Revenue 74.33B
Average Earnings Estimates
Qtr (09/15) Qtr (12/15) FY (12/15) FY (12/16)
Average Estimate $1.44 $1.44 $6.16 $6.39
Number of Analysts 10 8 12 12
High Estimate $1.48 $1.53 $6.20 $6.49
Low Estimate $1.35 $1.40 $6.12 $6.21
Prior Year $1.50 $1.27 $5.97 $6.16
Growth Rate (Year over Year) -4.13% 13.58% 3.20% 3.68%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Keep in mind, QE had some unintended consequences.
This 15-stock basket offers a stable and growing income stream along with appreciation potential.
Limit your purchases to high-yielding industry standouts.
Who knows. But with no shortage of negatives, it's hard to get excited at current valuations.
Earnings season can provide valuable insight into the health of the economy.
These stocks will be up so high today, that many fans will say "no thanks."
I am happy to be sitting in for Doug Kass for the second day in a row here on the Daily Dairy.
The market is off to a tepid start after rallying for three straight days -- certainly understandable, and some profit taking should be expected as we trade up near the highs of the relatively narrow trading range that has existed throughout most of 2015.
We're getting into the meat of the earnings season. Nice top- and bottom-line beat by JPMorgan Chase (JPM), which did a solid job of controlling costs. Also nice to see legal expenses drop. Hopefully we are near end of the pound-of-flesh regulatory gauntlet major banks have had to endure over the past five years. Johnson & Johnson (JNJ) beats slightly on the top and bottom lines as well.

Columnist Conversations

Dave - When we look at more people leaving the work force than the number of jobs being added, it become pret...
We added back some puts we sold yesterday a bit earlier this am. BOUGHT SPY SEPT 192 PUT AT 4.04 BOUGHT DIA SE...
1. It was a good move tactically to cover yesterday's SPY short. 2. It will prove to be a bad move tactically ...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.